Rohit Aggarwal, MD
Rheumatology · Pittsburgh, PANPI 1538340138
Payments from drug & device makers
Across 378 payments — averaging $16,487 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$4.9M
- E.r. Squibb & Sons, L.L.C.$337K
- Mallinckrodt Hospital Products Inc.$176K
- Janssen Research & Development, LLC$158K
- Pfizer$122K
- Mallinckrodt Enterprises LLC$106K
- plus $446K from 29 others
Across 8 payments — averaging $8420.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Octapharma USA, Inc.$62K
- Pfizer$6K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 39 | $4,885,717 |
| E.r. Squibb & Sons, L.L.C. | 41 | $337,371 |
| Mallinckrodt Hospital Products Inc. | 3 | $176,109 |
| Janssen Research & Development, LLC | 25 | $158,396 |
| Pfizer | 29 | $122,410 |
| Mallinckrodt Enterprises LLC | 1 | $106,040 |
| CSL Behring | 34 | $84,219 |
| AstraZeneca(2 entities) | 27 | $71,652 |
| Octapharma USA, Inc. | 58 | $69,594 |
| Astrazeneca UK Limited | 13 | $55,541 |
| Novartis | 21 | $35,956 |
| Boehringer Ingelheim International GmbH | 17 | $32,937 |
| Argenx US, Inc. | 13 | $25,885 |
| Bristol Myers Squibb | 9 | $13,110 |
| EMD Serono, Inc. | 3 | $10,013 |
| Merck | 8 | $8,002 |
| AbbVie | 1 | $6,750 |
| ANI Pharmaceuticals, Inc. | 5 | $5,906 |
| Janssen Global Services, LLC | 3 | $5,010 |
| Eli Lilly | 5 | $3,776 |
| UCB SA | 1 | $3,420 |
| Amgen | 1 | $2,744 |
| Sanofi | 1 | $2,292 |
| EMD Serono Research & Development Institute, Inc. | 1 | $2,213 |
| Jubilant Draximage Inc. | 1 | $2,000 |
| GSK | 3 | $1,998 |
| Teva Pharmaceuticals USA, Inc. | 1 | $1,408 |
| Beigene, Ltd. | 1 | $620 |
| Sobi, Inc | 6 | $504 |
| Vertex | 1 | $375 |
| Medtronic | 1 | $123 |
| Sun Pharmaceutical Industries Inc. | 1 | $87 |
| Johnson & Johnson | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
| Stratus Medical, LLC | 2 | $13 |
How this compares
$6,232,222 in reported general payments places this provider in the 95th percentile of 351 rheumatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Pittsburgh
- Siamak Moghadam-KiaPittsburgh$1.9M
- Chester OddisPittsburgh$646K
- Andreea CocaPittsburgh$551K
- Sebastian Sattui CortesPittsburgh$542K
- Susan ManziPittsburgh$468K
- Michael LuckePittsburgh$292K
- Tarun SharmaPittsburgh$275K
- Robyn DomsicPittsburgh$190K
- Kimberly LiangPittsburgh$148K
- Sonia ManochaPittsburgh$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.